Connect with us
European stocks moved on earnings and broker actions. Evotec, BioGaia, Plus500, Pharming, Inwido, Amundi and Julius Baer rallied on upgrades, strong results, growth outlooks and strategic...
Gilead is acquiring German biotech firm Tubulis for up to $5 billion, benefiting Evotec, which holds a 3.14 percent stake and expects about $100 million upfront...
Evotec SE remains in focus after a turbulent year marked by a profit warning, cyberattack, and leadership change. The Hamburg-based biotech partner works with firms like...
BioNTech saw a sharp drop in profits, starting 2024 with a €315 million loss, down from a €502 million profit the previous year, and sales plummeting...